Correlation Between ICL Israel and Cannassure Therapeutics

Can any of the company-specific risk be diversified away by investing in both ICL Israel and Cannassure Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ICL Israel and Cannassure Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ICL Israel Chemicals and Cannassure Therapeutics, you can compare the effects of market volatilities on ICL Israel and Cannassure Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ICL Israel with a short position of Cannassure Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ICL Israel and Cannassure Therapeutics.

Diversification Opportunities for ICL Israel and Cannassure Therapeutics

-0.77

Correlation Coefficient

ICL Israel  Cannassure Therapeutics

Pay attention - limited upside

The 3 months correlation between ICL and Cannassure is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding ICL Israel Chemicals and Cannassure Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cannassure Therapeutics and ICL Israel is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ICL Israel Chemicals are associated (or correlated) with Cannassure Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cannassure Therapeutics has no effect on the direction of ICL Israel i.e., ICL Israel and Cannassure Therapeutics go up and down completely randomly.

Pair Corralation between ICL Israel and Cannassure Therapeutics

Assuming the 90 days trading horizon ICL Israel Chemicals is expected to generate 0.45 times more return on investment than Cannassure Therapeutics. However, ICL Israel Chemicals is 2.23 times less risky than Cannassure Therapeutics. It trades about 0.2 of its potential returns per unit of risk. Cannassure Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  172,363  in ICL Israel Chemicals on December 30, 2024 and sell it today you would earn a total of  41,537  from holding ICL Israel Chemicals or generate 24.1% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

ICL Israel Chemicals  vs.  Cannassure Therapeutics

ICL Israel Chemicals

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in ICL Israel Chemicals are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak essential indicators, ICL Israel sustained solid returns over the last few months and may actually be approaching a breakup point.

Cannassure Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cannassure Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Cannassure Therapeutics is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with ICL Israel and Cannassure Therapeutics

The main advantage of trading using opposite ICL Israel and Cannassure Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ICL Israel position performs unexpectedly, Cannassure Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cannassure Therapeutics will offset losses from the drop in Cannassure Therapeutics' long position.

The idea behind ICL Israel Chemicals and Cannassure Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.